WELCOME TO
KRUER LAB

At the Kruer Lab, we aim to uncover the molecular basis and characterize the neurophysiological features of early-onset neurodevelopmental and neurodegenerative movement disorders and seek innovative therapies to treat them. Pediatric movement disorders are often complex and heterogeneous. They can also affect a child’s ability to speak, walk, and use their hands purposefully. Existing treatments for pediatric movement disorders are often inadequate, and the genetic basis of the disease is often unknown. Our work is inherently translational but focused on fundamental mechanisms that alter metabolism, early neuronal development, and cellular responses to cytotoxic stressors.